[In vitro activity of chloroquine, two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum]. 1986

S Fu, and A Björkman, and D Ofori-Adjei, and B Wählin, and O Ericsson, and F Sjöqvist

UI MeSH Term Description Entries
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D009287 Naphthyridines A group of two-ring heterocyclic compounds consisting of a NAPHTHALENES double ring in which two carbon atoms, one per each ring, are replaced with nitrogens.
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

S Fu, and A Björkman, and D Ofori-Adjei, and B Wählin, and O Ericsson, and F Sjöqvist
May 1984, Lancet (London, England),
S Fu, and A Björkman, and D Ofori-Adjei, and B Wählin, and O Ericsson, and F Sjöqvist
December 2010, Antimicrobial agents and chemotherapy,
S Fu, and A Björkman, and D Ofori-Adjei, and B Wählin, and O Ericsson, and F Sjöqvist
October 1992, Annals of tropical medicine and parasitology,
S Fu, and A Björkman, and D Ofori-Adjei, and B Wählin, and O Ericsson, and F Sjöqvist
January 2002, Experimental parasitology,
S Fu, and A Björkman, and D Ofori-Adjei, and B Wählin, and O Ericsson, and F Sjöqvist
March 1996, The Journal of antimicrobial chemotherapy,
S Fu, and A Björkman, and D Ofori-Adjei, and B Wählin, and O Ericsson, and F Sjöqvist
June 1993, Indian journal of malariology,
S Fu, and A Björkman, and D Ofori-Adjei, and B Wählin, and O Ericsson, and F Sjöqvist
January 1988, The American journal of tropical medicine and hygiene,
S Fu, and A Björkman, and D Ofori-Adjei, and B Wählin, and O Ericsson, and F Sjöqvist
January 2001, Journal of postgraduate medicine,
S Fu, and A Björkman, and D Ofori-Adjei, and B Wählin, and O Ericsson, and F Sjöqvist
May 1981, The American journal of tropical medicine and hygiene,
S Fu, and A Björkman, and D Ofori-Adjei, and B Wählin, and O Ericsson, and F Sjöqvist
September 1986, British journal of clinical pharmacology,
Copied contents to your clipboard!